AI-generated summary
The authors studied whether a pulsed 445-nm blue laser could relax arteries by activating nitric oxide signaling, using rat mesenteric arteries and cord blood-derived endothelial progenitor cells. They report that the laser induced vasorelaxation without vasocontraction and increased nitric oxide production, both of which were inhibited by a nitric oxide synthase inhibitor. These are laboratory findings, and the authors suggest possible future use for hypertension but do not establish clinical benefit.
- Who or what was studied
- Rat mesenteric arteries and cord blood-derived endothelial progenitor cells (laboratory tissue and cell study)
- Wavelengths
- 445 nm
- Limits stated in the abstract
- The study used isolated rat arteries and cultured cells rather than human participants, so clinical effects are not shown.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Nitric oxide, Phototherapy, Ultraviolet. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.